Considering the significant role of the midline and intralaminar nuclei of the thalamus in fear learning and responses to aversive stimuli, our data indicate that CaV3.1 T-channels may be a promising novel drug target for treating altered fear responses associated with multiple brain disorders. This evidence concerns the gene CACNA1G and brain disorder.